These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6977643)

  • 1. Inhibition of graft rejection by LPS: further evidence for effects on T lymphocytes.
    Winchurch RA; Hilberg C; Birmingham W; Munster AM
    J Reticuloendothel Soc; 1982 Jan; 31(1):31-42. PubMed ID: 6977643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-specific inhibitory processes of immunological and mitogenic cellular responses.
    Liacopoulos M; Lambert F; Liacopoulos P
    Immunology; 1980 Sep; 41(1):143-52. PubMed ID: 6448806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages.
    Jones B; Jones TC
    Immunology; 1978 Feb; 34(2):247-55. PubMed ID: 414994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
    Ruybal P; Gravisaco MJ; Barcala V; Escalada A; Di Sciullo P; Waldner C; Mongini C
    Vaccine; 2008 Jan; 26(5):697-705. PubMed ID: 18155328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.
    Krulová M; Zajícová A; Fric J; Holán V
    Transpl Int; 2002 Mar; 15(2-3):108-16. PubMed ID: 11935167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxin-induced T lymphocyte proliferation.
    Vogel SN; Hilfiker ML; Caulfield MJ
    J Immunol; 1983 Apr; 130(4):1774-9. PubMed ID: 6601137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anisomycin inhibits the behaviors of T cells and the allogeneic skin transplantation in mice.
    Xing F; Yu Z; Liu J; Di J; Zeng S; Chen D; Chen L; Fang Z; Guo Z; Pan S; Wang J; Li Y; Hao W; Fan Z; Teng Z; Chen G; Chen Z; Mao C; Long Y; Liu N
    J Immunother; 2008; 31(9):858-70. PubMed ID: 18833001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment of donor stimulator cells by 16,16 dimethyl prostaglandin E2 influences the recipient immune response.
    Chung SW; Gould B; Zhang R; Hu Y; Levy GA; Gorczynski RM
    Surgery; 1998 Feb; 123(2):171-80. PubMed ID: 9481403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated allograft responses in vitro. VI. Studies on macrophage-mediated cytotoxicity.
    Pfizenmaier K; Trostmann H; Röllinghoff M; Wagner H
    Immunology; 1975 Dec; 29(6):967-76. PubMed ID: 1081494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of costimulatory pathway modulation on corneal allograft survival.
    Watson MP; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3417-22. PubMed ID: 16877411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective loss of suppressor cell function in New Zealand mice induced by NTA.
    Klassen LW; Krakauer RS; Steinberg AD
    J Immunol; 1977 Sep; 119(3):830. PubMed ID: 19534
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of T cells in allografted tumor rejection: IFN-gamma released from T cells is essential for induction of effector macrophages in the rejection site.
    Yoneda Y; Yoshida R
    J Immunol; 1998 Jun; 160(12):6012-7. PubMed ID: 9637516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study of immunological tolerance induced by cytotoxic T lymphocyte-associated antigen 4 immunoglobulin in fresh bone allografts].
    Guo C; Dai K; Tang T
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 May; 19(5):381-5. PubMed ID: 15960444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional lymphoma capable of restoring the thymic response of an allogeneic mouse].
    Piazzon I; Déroche A; Matusevich M; Pasqualini CD
    Medicina (B Aires); 1979; 39(3):351-6. PubMed ID: 42002
    [No Abstract]   [Full Text] [Related]  

  • 19. Preferential induction of autoantibody secretion in polyclonal activation by peptidoglycan and lipopolysaccharide. I. In vitro studies.
    Dziarski R
    J Immunol; 1982 Mar; 128(3):1018-25. PubMed ID: 7035553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice.
    Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P
    J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.